Literature DB >> 2097493

Vaccination of chickens with a Salmonella enteritidis aroA live oral Salmonella vaccine.

G L Cooper1, R A Nicholas, G A Cullen, C E Hormaeche.   

Abstract

A mouse-virulent strain of Salmonella enteritidis, Se795 (LD50 less than 10 organisms for mice), was non-virulent for 12-day-old chickens given 10(6) cfu intravenously; the organisms were cleared from liver and spleen by day 14 as measured by direct plating and by day 21 by enrichment. An Se795aroA mutant, CU58, was also cleared from liver and spleen by day 14 after intravenous inoculation of 10(7) cfu. Day-old chicks vaccinated orally with either one dose of 10(9) CU58 at 1 day of age, 10(7) at 1 and 14 days, or 10(5) at 1 and 7 days followed by 10(9) at 14 and 21 days of age, were challenged orally with a nalidixic acid resistant variant of the virulent phage type 4 S. enteritidis strain 109. All vaccinated groups showed a reduction in faecal shedding of the challenge. Chickens given four doses of CU58 showed a significant reduction of cfu in liver, spleen and faeces following intravenous challenge with virulent strain 109. Intramuscular vaccination with 10(9) cfu of Aro strain CU58 at 1 day of age gave no protection against oral challenge with virulent strain 109. Serum antibody production to LPS (ELISA) was minimal in all vaccinated birds. The results indicate that oral vaccination with Aro- S. enteritidis can confer protection to day old chicks against virulent S. enteritidis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2097493     DOI: 10.1016/0882-4010(90)90014-h

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  8 in total

1.  Pathogenic role of SEF14, SEF17, and SEF21 fimbriae in Salmonella enterica serovar enteritidis infection of chickens.

Authors:  G Rajashekara; S Munir; M F Alexeyev; D A Halvorson; C L Wells; K V Nagaraja
Journal:  Appl Environ Microbiol       Date:  2000-04       Impact factor: 4.792

2.  Correlates of protection induced by live Aro- Salmonella typhimurium vaccines in the murine typhoid model.

Authors:  J A Harrison; B Villarreal-Ramos; P Mastroeni; R Demarco de Hormaeche; C E Hormaeche
Journal:  Immunology       Date:  1997-04       Impact factor: 7.397

3.  Characterization of a Salmonella typhimurium aro vaccine strain expressing the P.69 antigen of Bordetella pertussis.

Authors:  R Strugnell; G Dougan; S Chatfield; I Charles; N Fairweather; J Tite; J L Li; J Beesley; M Roberts
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

4.  Oral immunization of mice and swine with an attenuated Salmonella choleraesuis [delta cya-12 delta(crp-cdt)19] mutant containing a recombinant plasmid.

Authors:  T J Stabel; J E Mayfield; D C Morfitt; M J Wannemuehler
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

5.  Influence of preimmunization with tetanus toxoid on immune responses to tetanus toxin fragment C-guest antigen fusions in a Salmonella vaccine carrier.

Authors:  J A Chabalgoity; B Villareal-Ramos; C M Khan; S N Chatfield; R D de Hormaeche; C E Hormaeche
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

6.  Evaluation of the live vaccine efficacy of virulence plasmid-cured, and phoP- or aroA-deficient Salmonella enterica serovar Typhimurium in mice.

Authors:  Hidenori Matsui; Yasunori Isshiki; Masahiro Eguchi; Yohsuke Ogawa; Yoshihiro Shimoji
Journal:  J Vet Med Sci       Date:  2014-10-24       Impact factor: 1.267

7.  Relevant Genes Linked to Virulence Are Required for Salmonella Typhimurium to Survive Intracellularly in the Social Amoeba Dictyostelium discoideum.

Authors:  Sebastián Riquelme; Macarena Varas; Camila Valenzuela; Paula Velozo; Nicolás Chahin; Paulina Aguilera; Andrea Sabag; Bayron Labra; Sergio A Álvarez; Francisco P Chávez; Carlos A Santiviago
Journal:  Front Microbiol       Date:  2016-08-23       Impact factor: 5.640

8.  Inorganic Polyphosphate Is Essential for Salmonella Typhimurium Virulence and Survival in Dictyostelium discoideum.

Authors:  Macarena A Varas; Sebastián Riquelme-Barrios; Camila Valenzuela; Andrés E Marcoleta; Camilo Berríos-Pastén; Carlos A Santiviago; Francisco P Chávez
Journal:  Front Cell Infect Microbiol       Date:  2018-01-30       Impact factor: 5.293

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.